X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-10-02 | AXNX | Keese Kari Leigh | CFO | S - Sale | $69.41 | -2,961 | 40,362 | -7% | -$205,512 | ||||||
| D | 2024-01-31 | AXNX | Noblett Karen | Chief Medical Officer | S - Sale+OE | $67.74 | -11,288 | 34,428 | -25% | -$764,603 | |||||
| D | 2024-01-31 | AXNX | Woock John | EVP, Chief Mktg, Strtgy Office | S - Sale+OE | $67.74 | -15,899 | 77,403 | -17% | -$1,076,933 | |||||
| D | 2024-01-31 | AXNX | Ford Alfred J Jr | Chief Commercial Officer | S - Sale+OE | $67.74 | -16,615 | 43,450 | -28% | -$1,125,432 | |||||
| D | 2024-01-31 | AXNX | Keese Kari Leigh | CFO | S - Sale+OE | $67.74 | -3,489 | 43,323 | -7% | -$236,331 | |||||
| D | 2024-01-31 | AXNX | Cohen Raymond W | CEO | S - Sale+OE | $67.74 | -35,161 | 188,835 | -16% | -$2,381,662 | |||||
2024-01-08 | AXNX | Noblett Karen | Chief Medical Officer | S - Sale | $69.00 | -15,999 | 18,216 | -47% | -$1,103,961 | ||||||
| M | 2023-12-26 | AXNX | Noblett Karen | Chief Medical Officer | S - Sale | $63.25 | -8,000 | 34,215 | -19% | -$505,964 | |||||
| D | 2023-09-29 | AXNX | Dearen Danny L. | Pres, CFO | S - Sale+OE | $56.87 | -7,675 | 23,777 | -24% | -$436,490 | |||||
| A | 2022-02-03 | AXNX | Dearen Danny L. | Pres, CFO | S - Sale | $48.25 | -18,684 | 39,235 | -32% | -$901,542 | |||||
2023-08-15 | AXNX | Ford Alfred J Jr | Chief Commercial Officer | S - Sale | $62.34 | -14,769 | 34,565 | -30% | -$920,671 | ||||||
2023-07-28 | AXNX | Ford Alfred J Jr | Chief Commercial Officer | S - Sale | $62.01 | -1,500 | 49,334 | -3% | -$93,021 | ||||||
2023-05-26 | AXNX | Dearen Danny L. | Pres, CFO | S - Sale | $49.46 | -7,999 | 9,202 | -47% | -$395,646 | ||||||
| D | 2023-04-21 | AXNX | Dearen Danny L. | Pres, CFO | S - Sale+OE | $60.21 | -20,000 | 17,201 | -54% | -$1,204,137 | |||||
| D | 2023-04-20 | AXNX | Dearen Danny L. | Pres, CFO | S - Sale+OE | $60.01 | -2,001 | 23,993 | -8% | -$120,073 | |||||
| D | 2023-03-31 | AXNX | Dearen Danny L. | Pres, CFO | S - Sale+OE | $55.27 | -15,000 | 23,993 | -38% | -$829,103 | |||||
2023-02-21 | AXNX | Sama Rinda | COO | S - Sale | $56.31 | -23,321 | 56,462 | -29% | -$1,313,165 | ||||||
| DM | 2023-01-31 | AXNX | Sama Rinda | COO | S - Sale+OE | $61.09 | -18,500 | 79,783 | -19% | -$1,130,157 | |||||
| DM | 2023-01-31 | AXNX | Ford Alfred J Jr | Chief Commercial Officer | S - Sale+OE | $61.07 | -9,939 | 50,834 | -16% | -$606,985 | |||||
| DM | 2023-01-31 | AXNX | Dearen Danny L. | Pres, CFO | S - Sale+OE | $61.10 | -13,757 | 23,993 | -36% | -$840,605 | |||||
| DM | 2023-01-31 | AXNX | Cohen Raymond W | CEO | S - Sale+OE | $61.09 | -31,021 | 160,596 | -16% | -$1,895,173 | |||||
| DM | 2023-01-31 | AXNX | Noblett Karen | Chief Medical Officer | S - Sale+OE | $61.11 | -4,634 | 42,215 | -10% | -$283,164 | |||||
| DM | 2023-01-31 | AXNX | Woock John | EVP, Chief Mktg, Strtgy Office | S - Sale+OE | $61.07 | -11,549 | 65,302 | -15% | -$705,299 | |||||
| D | 2023-01-17 | AXNX | Woock John | EVP, Chief Mktg, Strtgy Office | S - Sale+OE | $67.34 | -30,215 | 45,976 | -40% | -$2,034,531 | |||||
2023-01-13 | AXNX | Cohen Raymond W | CEO | S - Sale | $65.94 | -40,736 | 108,899 | -27% | -$2,686,001 | ||||||
| D | 2023-01-13 | AXNX | Ford Alfred J Jr | Chief Commercial Officer | S - Sale+OE | $66.40 | -36,015 | 36,773 | -49% | -$2,391,415 | |||||
2022-12-13 | AXNX | Lopez Esteban | Dir | S - Sale | $67.42 | -2,000 | 3,600 | -36% | -$134,840 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |